See more : Prologue SA (PROBT.PA) Income Statement Analysis – Financial Results
Complete financial analysis of InhaleRx Limited (IRX.AX) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of InhaleRx Limited, a leading company in the Medical – Devices industry within the Healthcare sector.
- Gauzy Ltd. Ordinary Shares (GAUZ) Income Statement Analysis – Financial Results
- Smith & Nephew plc (SNN) Income Statement Analysis – Financial Results
- Geojit Financial Services Limited (GEOJITFSL.BO) Income Statement Analysis – Financial Results
- Life Intelligent Enterprise Holdings Co.,Ltd. (5856.T) Income Statement Analysis – Financial Results
- Associated British Foods plc (ABF.L) Income Statement Analysis – Financial Results
InhaleRx Limited (IRX.AX)
About InhaleRx Limited
InhaleRx Limited engages in the developing and commercializing of medical drug delivery systems in Australia. It also develops inhaled drug formulations. Its solutions include Medihale inhaler, a sealed pod inhaler for use with inhaled formulations. The company was formerly known as Lifespot Health Ltd and changed its name to InhaleRx Limited in October 2021. InhaleRx Limited was incorporated in 2016 and is based in Sydney, Australia.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 1.20M | 24.80K | 167.30K | 97.50K | 46.60K | 345.79K | 493.31K | 996.00 |
| Cost of Revenue | 0.00 | 9.71K | 115.23K | 123.92K | 622.65K | 1.32M | 1.77M | 105.00 |
| Gross Profit | 1.20M | 15.09K | 52.07K | -26.43K | -576.05K | -971.19K | -1.28M | 891.00 |
| Gross Profit Ratio | 100.00% | 60.86% | 31.12% | -27.11% | -1,236.19% | -280.86% | -259.11% | 89.46% |
| Research & Development | 1.45M | 977.14K | 116.99K | 201.16K | 7.61K | 87.60K | 0.00 | 0.00 |
| General & Administrative | 828.10K | 514.47K | 559.37K | 308.51K | 785.42K | 1.36M | 895.00K | 190.00K |
| Selling & Marketing | 33.30K | 33.88K | 52.35K | 41.47K | 47.06K | 48.50K | 47.68K | 0.00 |
| SG&A | 1.14M | 548.35K | 611.71K | 349.98K | 832.49K | 1.41M | 942.68K | 190.00K |
| Other Expenses | 0.00 | 10.92K | 14.44K | 9.57K | 273.81K | 30.79K | 3.48K | 747.00 |
| Operating Expenses | 2.59M | 1.95M | 1.18M | 994.78K | 2.15M | 2.33M | 2.61M | 349.22K |
| Cost & Expenses | 2.59M | 1.95M | 1.29M | 1.12M | 2.15M | 2.33M | 2.61M | 349.22K |
| Interest Income | 2.03K | 16.13K | 334.00 | 292.00 | 19.07K | 54.71K | 38.74K | 0.00 |
| Interest Expense | 8.11K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 9.71K | 9.71K | 1.81K | 61.15K | 61.15K | 81.49K | 143.58K | 105.00 |
| EBITDA | -1.41M | -1.94M | -1.12M | -1.22M | -1.84M | -1.89M | -2.66M | -348.26K |
| EBITDA Ratio | -117.42% | -7,754.58% | -671.90% | -1,047.44% | -3,389.20% | -551.28% | -362.06% | -35,051.31% |
| Operating Income | -1.39M | -1.92M | -1.13M | -1.02M | -1.64M | -1.99M | -2.05M | -349.22K |
| Operating Income Ratio | -115.15% | -7,756.68% | -672.98% | -1,047.44% | -3,520.43% | -574.68% | -414.91% | -35,061.85% |
| Total Other Income/Expenses | -1.26M | -3.39K | 334.00 | -91.11K | -400.49K | -170.81K | -491.00K | 63.76K |
| Income Before Tax | -2.65M | -1.90M | -1.11M | -1.01M | -2.27M | -1.95M | -2.15M | -348.36K |
| Income Before Tax Ratio | -219.87% | -7,647.60% | -664.15% | -1,037.33% | -4,877.06% | -563.46% | -435.46% | -34,976.31% |
| Income Tax Expense | -1.20M | -16.13K | -334.00 | -61.44K | 443.45K | -26.60K | -53.12K | -105.00 |
| Net Income | -1.44M | -1.90M | -1.11M | -1.01M | -2.27M | -1.87M | -2.10M | -348.36K |
| Net Income Ratio | -119.87% | -7,647.60% | -664.15% | -1,037.33% | -4,877.06% | -542.20% | -424.69% | -34,976.31% |
| EPS | -0.01 | -0.01 | -0.01 | -0.01 | -0.03 | -0.02 | -0.03 | -0.01 |
| EPS Diluted | -0.01 | -0.01 | -0.01 | -0.01 | -0.03 | -0.02 | -0.03 | -0.01 |
| Weighted Avg Shares Out | 189.38M | 173.05M | 167.57M | 99.19M | 79.93M | 77.87M | 77.20M | 25.81M |
| Weighted Avg Shares Out (Dil) | 189.36M | 173.05M | 167.57M | 99.19M | 79.93M | 77.87M | 77.20M | 26.62M |
Source: https://incomestatements.info
Category: Stock Reports